Combined effect of cyclocytidine and lentinan of spontaneous mammary tumors in mice.
Cytotoxic cytidine analog, cyclocytidine, and antitumor immunopotentiator, lentinan, offered an opportunity of testing the effect of combined modality of cytocidal agent and immunopotentiator on spontaneous mammary tumors of mice. Lentinan did not improve the therapeutic effect of cyclocytidine; it only prevented the early toxic death of mice due to cyclocytidine in one strain of mice but not in the other strain.
D000818:Animals; D004359:Drug Therapy, Combination; D005260:Female; D007912:Lentinan / Q000008:administration & dosage / Q000627:therapeutic use*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D051379:Mice; D008809:Mice, Inbred C3H; D011134:Polysaccharides / Q000627:therapeutic use*
D011134:Polysaccharides; D007912:Lentinan